The FDA has approved a drug that is used in the treatment of acne, which it said was safe and effective.
The drug, a beta-hydroxybutyrate, is part of the company’s new line of products.
The FDA said it was approved to treat moderate to severe acne with albendazole, which is approved by the Food and Drug Administration for the treatment and prevention of acne.
It also said the drug has been shown to reduce the severity of the disease and may help in treating more severe cases of acne that can occur in people who have the disease.
The drug, known as albendingazole and made by AstraZeneca, is also the first approved drug to treat the inflammatory acne of the rosacea.
AstraZap said in a statement it was working with the FDA on the approval.
The approval is the first drug approved by regulators in the United States for the inflammatory skin condition and the first in the world to be approved for that condition.